Ogden Phipps said Oct. 6 a centralized regulatory body for horse racing would facilitate changes necessary to improve the integrity of the sport in the United States, but the chances of it happening are slim to none.
Two of three distinguished veterinarians being honored by the Thoroughbred Club of American, Dr. Larry Bramlage and Dr. Gary Lavin, addressed medication use in racehorses during their acceptance speeches.
In response to a statement from 25 prominent horsemen calling for a ban on the race-day use of furosemide, the Florida Horsemen's Benevolent and Protective Association Aug. 8 issued an open letter opposing changes.
In response to several top trainers calling for the end of race-day furosemide, horsemen's groups throughout the country say they will continue to support the use of the diuretic to prevent or reduce the severity of EIPH.
Some of North America's top trainers are backing a plan to eliminate the use of race-day medication in the U.S. beginning next season with 2-year-olds, and expanding to all horses in 2016.
Breeders' Cup chairman Bill Farish acknowledged the organization's board of directors has some key issues it needs to address, not the least of which is the host-site selection process.
For the second year in a row, many of horse racing's top owners have pledged to race their juvenile starters without race-day medication.
The West Virginia Racing Commission heard the pros and cons of race-day furosemide use Sept. 17 and pledged to examine the steps necessary to implement mandatory administration of the anti-bleeding drug by third-party vets.
During a June 29 meeting that showed the battle over race-day furosemide is escalating, supporters ripped their opponents and vowed to take their case -- that the medication is good for the racehorse -- to the public.
- By Tom LaMarra
Regulators around the country are examining the Kentucky Horse Racing Commission's move to phase out race-day furosemide in graded and listed stakes beginning in 2014, but there doesn't appear to be a rush to follow suit.
The controversial subject of furosemide, the anti-bleeder medication widely used in North American racing, will be the subject of the next "Talkin' Horses with The Blood-Horse" live podcast at 2 p.m. EDT, Tuesday, June 26.
- By Tom LaMarra
The Thoroughbred Racing Associations has endorsed a policy for medication reform that has been supported by many industry stakeholders but so far acted upon piecemeal in various jurisdictions.
In a development that figures to play out in other racing states, two New York senators said June 12 the anti-bleeding medication furosemide should not be banned on race day.
In advance of an expected vote by the Kentucky Horse Racing Commission June 13, the American Graded Stakes Committee reaffirmed its desire to ban all race-day medication in graded stakes for 2-year-olds.
The Pennsylvania Equine Coalition said June 11 it is closer to consensus on "action items" designed to improve the health and safety of equines and humans at racetracks in the state.
During an oddly lopsided meeting on a proposal to phase-out use of furosemide on race day in listed and graded stakes in Kentucky, proponents of the therapeutic anti-bleeding medication made their case. But it may not matter.
The Kentucky Horse Racing Commission has scheduled a town hall meeting for June 5 to discuss the proposed three-year phase-out of the race-day drug furosemide.
There doesn't seem to be any middle ground in the debate over the anti-bleeding drug furosemide, and it seems doubtful the two sides will come together any time soon.
The Kentucky Horse Racing Commission May 16 kept alive a proposed regulation to phase out over three years race-day furosemide for graded and listed stakes, but not before the Equine Drug Research Council voted to reject it.
The Jockey Club May 15 released an eight-page letter it submitted to the New York State Racing and Wagering Board the previous day in regard to use of the race-day medication and furosemide and other related issues.
The Kentucky Horse Racing Commission confirmed it will discuss but not take final action May 16 on a proposal for the three-year phase-out of race-day furosemide in graded and listed stakes.
The racing industry is closer to uniformity in drug regulations and penalties than many admit, but agreement on race-day anti-bleeding drugs in a "toxic" environment will require some heavy lifting, officials said May 2.
New York State Racing and Wagering Board chairman John Sabini says it's time for a fresh look at the state's race-day medication policy.
Thoroughbred racing got further bruises April 30 during an allegation-ridden congressional hearing into equine health and medication issues that furthered a call for federal intervention--at least on some level.
An effort to make Kentucky the first state to ban the anti-bleeder medication furosemide for racing purposes failed April 16 when the state's Horse Racing Commission voted 7-7 not to approve it.
The Kentucky Horsemen's Benevolent and Protective Association has requested Gov. Steve Beshear not to sign any request to implement on an emergency basis a ban on race-day use of furosemide.
The Thoroughbred Owners and Breeders Association's American Graded Stakes Committee announced Feb. 24 it has postponed implementing a ban on race-day medication in graded stakes races for 2-year-olds in 2012.
Panelists gathered for a Jan. 14 National Horsemen's Benevolent and Protective Association forum said there is no scientific evidence supporting a ban on the use of furosemide on race day.
Concept isn't new...but worth revisiting... read blog
If testimony taken Nov. 14 in Kentucky, a major breeding and racing state, is any indication, the battle over use of furosemide on race day doesn't figure to end any time soon.
The pros and cons of race-day medication in racehorses were debated Nov. 14 during a lengthy meeting of the Kentucky Horse Racing Commission Race Day Medication Committee at the state Capitol.
A Kentucky Horse Racing Commission committee will hold what could be a six- to seven-hour meeting on race-day medication Nov. 14 in Frankfort, the state capital.
Prominent George Strawbridge Jr. said the U.S. needs more strict enforcement and tougher penalties for medication use in racehorses.
- By Tom LaMarra
The Jockey Club has reiterated its calls for a phased-in ban on the anti-bleeding medication Salix but made clear Aug. 14 it wants "medication-free" horse racing.
- By Tom LaMarra
The American Graded Stakes Committee said Aug. 10 it will employ a pilot program that will ban race-day medications -- primarily the anti-bleeding drug Salix -- in graded 2-year-old stakes in 2012.
An industry consortium supports administration of Salix by regulatory veterinarians only and a ban on adjunct bleeder drugs, but will continue to study a pilot program proposal to ban the use of race-day Salix in 2-year-olds.
The National Horsemen's Benevolent and Protective Association said July 24 it supports elimination of race-day medication use with the exception of the anti-bleeding drug Salix.
Gulfstream Park has not set a timetable for possible future contact with Florida racing regulators on chairman Frank Stronach's goal of phasing out use of legal race-day medications such as the anti-bleeding drug Salix.
An Association of Racing Commissioners International committee will meet July 26 to hear opinions and testimony on use of race-day medication in racehorses.
Industry organizations that have weighed in so far are for the most part supportive of the plan by Breeders' Cup to phase out race-day medication use in the World Championships beginning in 2012.
Breeders' Cup said it will prohibit use of race-day medication in World Championships races for 2-year-olds in 2012 and all events in 2013.
A well-attended summit June 13 at Belmont Park shed a lot of light on the research and international regulations surrounding the race-day medication Salix.
Education was the primary mission of the June 13 International Summit on Race Day Medication, EIPH and the Racehorse held at Belmont Park in New York.
The Kentucky Equine Drug Research Council, citing its statutory mission, will be involved in the debate over race-day medication, officials said May 25.
The first 'International Summit on Race Day Medication, EIPH and the Racehorse' has been scheduled for June 13-14 in New York City.
- By Tom LaMarra
The American Association of Equine Practitioners has expressed concern with "very broad language" in federal legislation geared toward use of performance-enhancing drugs in racehorses.
A proposed federal bill would create a three-strikes-you're-out penalty system for anyone found guilty of racing a horse under the influence of a performance-enhancing drug.
As expected the Racing Medication and Testing Consortium board of directors said April 20 it will join the National Thoroughbred Racing Association and American Association of Equine Practitioners in organizing a drug summit.
Keeneland said April 20 it supports "a pragmatic approach" in efforts that could lead to racing being conducted medication-free.
- By Tom LaMarra
Industry organizations including the National Thoroughbred Racing Association will propose an international summit on equine medication this year in the wake of calls for the race-day ban of anti-bleeding drugs.
Most Popular Stories
- Jockey Chapa Faces Felony Race-Fixing Charges
- Final Call for Taylors of Seattle Slew Fame
- Steve Haskin's Derby Dozen for Jan. 27, 2015
- Washington Owner/Breeder Paxton Dead at 76
- Nerud-Owned and Bred Colt Wins at Big A
- The Week in Photos for 1/27/2015
- Jan. 28 Live Racing at Aqueduct Canceled
- Barretts Gross Up; Average, Median Decline
- WGOH: Avoiding the Nuclear Option
- Keeping Pace: Upstart Figures to Improve